New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2014
06:38 EDTSHPGShire likely to trade down 2%-3% on trial failure, says Leerink
Leerink expects shares of Shire to trade down 2%-3% today after Vyvanse failed to show efficacy in its Phase 3 depression) trial. Leerink thinks concerns surrounding Shire's pipeline success could heighten following the news but keeps an Outperform rating on the stock.
News For SHPG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 25, 2015
13:58 EDTSHPGShire initiated with a Reduce at HSBC
Price target GBP 47.34.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use